Çalışkan, B. Et Al. 2022. NOVEL MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 (mPGES-1) INHIBITOR AS A NEW MODALITY TO TREAT INFLAMMATION. EFMC-ISMC 2022 - XXVII EFMC International Symposium on Medicinal Chemistry , (Nice, France), 321.

Çalışkan, B., Ergül, A. G., Gür Maz, Z. T., Olğaç, A., & Banoğlu, E., (2022). NOVEL MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 (mPGES-1) INHIBITOR AS A NEW MODALITY TO TREAT INFLAMMATION . EFMC-ISMC 2022 - XXVII EFMC International Symposium on Medicinal Chemistry (pp.321). Nice, France

Çalışkan, Burcu Et Al. "NOVEL MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 (mPGES-1) INHIBITOR AS A NEW MODALITY TO TREAT INFLAMMATION," EFMC-ISMC 2022 - XXVII EFMC International Symposium on Medicinal Chemistry, Nice, France, 2022

Çalışkan, Burcu Et Al. "NOVEL MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 (mPGES-1) INHIBITOR AS A NEW MODALITY TO TREAT INFLAMMATION." EFMC-ISMC 2022 - XXVII EFMC International Symposium on Medicinal Chemistry , Nice, France, pp.321, 2022

Çalışkan, B. Et Al. (2022) . "NOVEL MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 (mPGES-1) INHIBITOR AS A NEW MODALITY TO TREAT INFLAMMATION." EFMC-ISMC 2022 - XXVII EFMC International Symposium on Medicinal Chemistry , Nice, France, p.321.

@conferencepaper{conferencepaper, author={Burcu Çalışkan Et Al. }, title={NOVEL MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 (mPGES-1) INHIBITOR AS A NEW MODALITY TO TREAT INFLAMMATION}, congress name={EFMC-ISMC 2022 - XXVII EFMC International Symposium on Medicinal Chemistry}, city={Nice}, country={France}, year={2022}, pages={321} }